A detailed history of Millrace Asset Group, Inc. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 25,503 shares of CDXC stock, worth $134,400. This represents 0.09% of its overall portfolio holdings.

Number of Shares
25,503
Holding current value
$134,400
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $64,012 - $96,911
25,503 New
25,503 $93,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $360M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.